Remdesivir: Confidence or Confusion?

Remdesivir: Confidence or Confusion?

By

|

Critical COVID-19 Treatment Update The global effort to discover safe and effective treatments for COVID-19 suffered a significant setback late last week when the World Health Organization (WHO) released its assessment of Remdesivir—a drug previously authorized in the United States for emergency use—suggesting that the drug provides little benefit for severely ill COVID-19 patients. The … Continued

Unmasking the Markets: Coronavirus News Affecting Active Investors

By

|

The COVID-19 pandemic remains the primary source of uncertainty in the global financial markets. The United States officially diagnosed its first case back on Jan. 20, and the number of infections in the country has now risen to over 4 million. Looking at the entirety of human civilization, at least 16 million individuals are infected … Continued